Cable Hill Partners, LLC Dynavax Technologies Corp Transaction History

Cable Hill Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$3.65 - $7.89 $2,430 - $5,254	-666 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$7.08 - $12.09 $24,780 - $42,315	-3,500 Reduced 84.01%	666 $5,000
Q4 2018 Feb 12, 2019	BUY	$8.14 - $13.28 $16,280 - $26,560	2,000 Added 92.34%	4,166 $38,000
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $6,280 - $8,480	-530 Reduced 19.66%	2,166 $24,000
Q2 2018 Aug 03, 2018	BUY	$15.15 - $20.75 $10,544 - $14,442	696 Added 34.8%	2,696 $41,000
Q3 2017 Oct 27, 2017	SELL	$15.2 - $21.5 $15,200 - $21,500	-1,000 Reduced 33.33%	2,000 $43,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,000	3,000 $30,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.69B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.